BIAL launches a new drug for Parkinson’s Disease.
BIAL, the largest Portuguese pharmaceutical company, saw its second research drug approved by the FDA.
It is a drug for Parkinson’s Disease that will start being marketed in the USA by the end of this year.
Portugal is a country open to business, which has not stopped producing and innovating in face of the COVID-19 crisis.
If you are interested in this company and its products or services and want to know more, please fill out the below form. We will get back to you shortly.